Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Jesse Lee Berry, MD

    TitleAssistant Professor of Clinical Ophthalmology
    SchoolKeck School of Medicine of USC
    DepartmentPediatrics
    AddressCHL 4650 Sunset Blvd
    Off Campus
    Los Angeles California 90027
    Phone+1 323 442 6578
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      Jesse L. Berry, MD, received her undergraduate and medical degree from Harvard University in Massachusetts. Following her ophthalmology residency at the University of Southern California, she was the assistant chief of service at the Los Angeles County Medical Center. She then completed a fellowship in Ocular Oncology at Children’s Hospital Los Angeles under the mentorship of Drs. Jonathan Kim and A. Linn Murphree. Dr. Berry is the founder of WOO, Women in Ocular Oncology.

      Evaluation of the aqueous humor for tumor-derived genetic information and its application to prognosis and precision medicine for retinoblastoma patients. Investigating new methods of chemotherapy delivery for the treatment of Retinoblastoma. Evaluating treatment outcomes for Retinoblastoma eyes. This includes evaluation of treatment outcomes after systemic chemotherapy and the elucidation of factors present at diagnosis, which contribute to final visual outcome in eyes treated for retinoblastoma.


      Collapse Biography 
      Collapse Education and Training
      Harvard UniversityBA2004
      Harvard Medical SchoolMD2008
      USC Roski Eye InstituteOphthalmology Residency2012
      Children's Hospital Los AngelesOcular Oncology Fellowship2014
      Collapse Awards and Honors
      2000  - 2004Harvard College Scholarship: Elizabeth Cary Agassiz Scholar
      2000  - 2004Malcolm Kinsberg Scholarship
      2002Kappa Alpha Theta Foundation Scholarship
      2003David Rockefeller Center of Latin American Studies Grant
      2004  - 2008Nevil & Louise Ford Scholarship Fund
      2005Harvard Medical International Initiatives in Research Grant
      2007Center for Eye Research and Education McCleary Grant
      2011Doheny Eye Institute Medical Knowledge Award
      2012Starr Schulman Fellowship
      2012Department of Health Services Innovation Grant
      2013Society of Heed Fellows
      2013  - 2014University of Southern California Excellence in Resident Teaching Award

      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Kim JW, Jacobsen BH, Ko M, Lee DK, Jubran RF, Berry J. Three presentations of CNS disease in patients with intraocular retinoblastoma at a tertiary medical center in the United States. Ophthalmic Genet. 2017 Sep 26; 1-5. PMID: 28949779.
        View in: PubMed
      2. Berry J, Shah S, Bechtold M, Zolfaghari E, Jubran R, Kim JW. Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era. Pediatr Blood Cancer. 2017 Jun 24. PMID: 28646513.
        View in: PubMed
      3. Berry J, Bechtold M, Shah S, Zolfaghari E, Reid M, Jubran R, Kim JW. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma. Ophthalmology. 2017 Jun 24. PMID: 28655537.
        View in: PubMed
      4. Wong BJ, Berry J. Acute Lymphoblastic Leukemia Relapse Presenting as Optic Nerve Infiltration. JAMA Ophthalmol. 2017 Jan 12; 135(1):e164656. PMID: 28030719.
        View in: PubMed
      5. Berry J, Kogachi K, Aziz HA, McGovern K, Zolfaghari E, Murphree AL, Jubran R, Kim JW. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation. Pediatr Blood Cancer. 2017 Apr; 64(4). PMID: 28221729.
        View in: PubMed
      6. Aziz HA, Kim JW, Munier FL, Berry J. Acute Hemorrhagic Retinopathy following Intravitreal Melphalan Injection for Retinoblastoma: A Report of Two Cases and Technical Modifications to Enhance the Prevention of Retinal Toxicity. Ocul Oncol Pathol. 2017 Jan; 3(1):34-40. PMID: 28275601.
        View in: PubMed
      7. Berry J, Shih G, Moysidis SN, Jubran R, Wong K, Lee TC, Murphree AL, Kim JW. Patterns of subretinal fluid resolution in Group D eyes treated with chemoreduction: Experience from the Children's Hospital Los Angeles/University of Southern California. Ophthalmic Genet. 2016 Dec; 37(4):400-403. PMID: 26934665.
        View in: PubMed
      8. Berry J, Cobrinik D, Kim JW. Detection and Intraretinal Localization of an 'Invisible' Retinoblastoma Using Optical Coherence Tomography. Ocul Oncol Pathol. 2016 Apr; 2(3):148-52. PMID: 27239455; PMCID: PMC4881267.
      9. Zhu D, Berry J, Ediriwickrema L, Wong K, Lee TC, Murphree AL, Kim JW, Jubran R. Long-Term Outcomes of Group B Eyes in Patients with Retinoblastoma Treated with Short-Course Chemoreduction: Experience from Children's Hospital Los Angeles/University of Southern California. Ocul Oncol Pathol. 2015 Dec; 2(2):105-11. PMID: 27172535; PMCID: PMC4847672.
      10. Jacobsen BH, Berry J, Jubran R, Kim JW. Orbital Recurrence following Aggressive Laser Treatment for Recurrent Retinoblastoma. Ocul Oncol Pathol. 2015 Dec; 2(2):76-9. PMID: 27171650; PMCID: PMC4847708.
      11. Berry J, Kim JW, Jennelle R, Astrahan M. Use of the Toric Surgical Marker to Aid in Intraoperative Plaque Placement for the USC Eye Physics Plaques to Treat Uveal Melanoma: A New Surgical Technique. Ophthalmic Surg Lasers Imaging Retina. 2015 Sep; 46(8):866-70. PMID: 26431303.
        View in: PubMed
      12. Browne AW, Dandapani SV, Jennelle R, Stevanovic M, Lee TC, Murphree AL, Kampp TD, Astrahan MA, Kim JW, Berry J. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling. Brachytherapy. 2015 Sep-Oct; 14(5):718-25. PMID: 26073224.
        View in: PubMed
      13. Berry J, Jubran R, Lee TC, Murphree AL, Lee D, Kim JW. Low-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age. Ocul Oncol Pathol. 2015 Feb; 1(2):103-10. PMID: 27172253; PMCID: PMC4847682.
      14. Berry J, Jubran R, Wong K, Lee TC, Murphree AL, Kim JW. Factors predictive of long-term visual outcomes of Group D eyes treated with chemoreduction and low-dose IMRT salvage: the Children's Hospital Los Angeles experience. Br J Ophthalmol. 2014 Aug; 98(8):1061-5. PMID: 24671926.
        View in: PubMed
      15. Berry J, Dandapani SV, Stevanovic M, Lee TC, Astrahan M, Murphree AL, Kim JW. Outcomes of choroidal melanomas treated with eye physics: a 20-year review. JAMA Ophthalmol. 2013 Nov; 131(11):1435-42. PMID: 24008431.
        View in: PubMed
      16. Berry J, Jubran R, Kim JW, Wong K, Bababeygy SR, Almarzouki H, Lee TC, Murphree AL. Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage. Pediatr Blood Cancer. 2013 Apr; 60(4):688-93. PMID: 22997170.
        View in: PubMed
      17. Berry J, Cuzzo LM, Bababeygy SR, Quiros PA. Unmet need for corrective eyeglasses: results from a Los Angeles County Hospital survey. Int Ophthalmol. 2012 Jun; 32(3):245-50. PMID: 22487855.
        View in: PubMed
      18. Lee NG, Berry J, Lee TC, Wang AT, Honowitz S, Murphree AL, Varshney N, Hinton DR, Fawzi AA. Sonoporation enhances chemotherapeutic efficacy in retinoblastoma cells in vitro. Invest Ophthalmol Vis Sci. 2011 Jun 01; 52(6):3868-73. PMID: 21273549; PMCID: PMC3109062.
      19. Mavroeidi A, O'Neill F, Lee PA, Darling AL, Fraser WD, Berry J, Lee WT, Reid DM, Lanham-New SA, Macdonald HM. Seasonal 25-hydroxyvitamin D changes in British postmenopausal women at 57 degrees N and 51 degrees N: a longitudinal study. J Steroid Biochem Mol Biol. 2010 Jul; 121(1-2):459-61. PMID: 20302933.
        View in: PubMed
      20. Berry J, Small RC, Foster RW. Tracheal relaxation induced by potassium channel opening drugs: its antagonism by adrenergic neurone blocking agents. Br J Pharmacol. 1992 Aug; 106(4):813-8. PMID: 1393280; PMCID: PMC1907678.
      21. Small RC, Berry J, Boyle JP, Chapman ID, Elliott KR, Foster RW, Watt AJ. Biochemical and electrical aspects of the tracheal relaxant action of AH 21-132. Eur J Pharmacol. 1991 Jan 17; 192(3):417-26. PMID: 1647318.
        View in: PubMed